Analysts Set Aemetis, Inc. (NASDAQ:AMTX) Price Target at $12.95

Aemetis, Inc. (NASDAQ:AMTX) has earned a consensus recommendation of “Moderate Buy” from the five research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $12.95.

A number of equities research analysts have recently weighed in on AMTX shares. HC Wainwright reiterated a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a research report on Monday, December 23rd. StockNews.com upgraded shares of Aemetis to a “sell” rating in a report on Friday, January 3rd.

Institutional Investors Weigh In On Aemetis

Several hedge funds have recently made changes to their positions in AMTX. Bank of New York Mellon Corp purchased a new position in Aemetis during the second quarter valued at $306,000. Rhumbline Advisers increased its stake in shares of Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after acquiring an additional 50,528 shares in the last quarter. Hutchinson Capital Management CA purchased a new position in Aemetis during the 2nd quarter valued at about $70,000. Susquehanna Fundamental Investments LLC boosted its stake in Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after acquiring an additional 93,536 shares in the last quarter. Finally, FMR LLC grew its holdings in Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after purchasing an additional 9,137 shares during the period. 27.02% of the stock is currently owned by institutional investors.

Aemetis Stock Up 1.8 %

NASDAQ:AMTX opened at $2.87 on Monday. The firm has a market capitalization of $142.74 million, a P/E ratio of -1.27 and a beta of 1.47. Aemetis has a 52 week low of $2.10 and a 52 week high of $7.03. The company has a fifty day moving average of $3.28 and a 200 day moving average of $2.97.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.09. The firm had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same period last year, the company posted ($0.59) earnings per share. As a group, analysts anticipate that Aemetis will post -2.02 EPS for the current year.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.